ProQR Therapeutics NV
NASDAQ:PRQR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ProQR Therapeutics NV
NASDAQ:PRQR
|
NL |
|
Anhui Jianghuai Automobile Group Corp Ltd
SSE:600418
|
CN |
|
Genesis Scale Holdings Ltd
F:92N0
|
HK |
|
L
|
Lepermislibre SA
PAR:ALLPL
|
FR |
|
MSCI Inc
NYSE:MSCI
|
US |
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
E
|
Essilorluxottica SA
DUS:ESL
|
FR |
|
N
|
Nousbo Co Ltd
KOSDAQ:332290
|
KR |
|
Universal Music Group NV
F:0VD0
|
NL |
|
A
|
Applied Industrial Technologies Inc
LSE:0HGR
|
US |
|
C
|
CT Automotive Group PLC
F:X7X
|
UK |
|
N
|
Northisle Copper and Gold Inc
OTC:NTCPF
|
CA |
|
Y
|
Yankuang Energy Group Co Ltd
XMUN:YZCA
|
CN |
|
Kioxia Holdings Corp
F:KI5
|
JP |
|
WSP Global Inc
TSX:WSP
|
CA |
|
Kitron ASA
OSE:KIT
|
NO |
|
N
|
Novo Nordisk A/S
DUS:NOVA
|
DK |
|
Charger Metals NL
ASX:CHR
|
AU |
|
R
|
Robinsons Land Corp
XPHS:RLC
|
PH |
Bankruptcy Probability
ProQR Therapeutics NV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
ProQR Therapeutics NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NL |
|
ProQR Therapeutics NV
NASDAQ:PRQR
|
189.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
506.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
242.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
197.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
83B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
59B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
39.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
ProQR Therapeutics NV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, ProQR Therapeutics NV has total debt of 8.7m EUR. This includes both short-term (0 EUR) and long-term (8.7m EUR) debt.
You can find a full breakdown on its Balance Sheet.